Healthcare provider profile · identity verified

Daniel Joseph Peterson, MD

Internal Medicine · WYNDMOOR, PA · NPI 1902883846

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	718	236
Amlodipine Besylate	Amlodipine Besylate	635	187
Losartan Potassium	Losartan Potassium	439	132
Atorvastatin Calcium	Atorvastatin Calcium	404	128
Pravastatin Sodium	Pravastatin Sodium	265	87
Levothyroxine Sodium	Levothyroxine Sodium	216	66
Lisinopril	Lisinopril	195	57
Gabapentin	Gabapentin	186	70
Fluticasone Propionate	Fluticasone Propionate	180	68
Omeprazole	Omeprazole	179	46
Metoprolol Succinate	Metoprolol Succinate	178	58
Pantoprazole Sodium	Pantoprazole Sodium	172	59
Olmesartan Medoxomil	Olmesartan Medoxomil	154	52
Famotidine	Famotidine	153	49
Albuterol Sulfate Hfa	Albuterol Sulfate	151	53
Hydrochlorothiazide	Hydrochlorothiazide	146	50
Metformin Hcl Er	Metformin Hcl	137	48
Jardiance	Empagliflozin	133	30
Nifedipine Er	Nifedipine	133	39
Montelukast Sodium	Montelukast Sodium	127	40
Sertraline Hcl	Sertraline Hcl	119	25
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	115	46
Simvastatin	Simvastatin	115	31
Carvedilol	Carvedilol	113	34
Furosemide	Furosemide	108	40
Ozempic	Semaglutide	105	17
Potassium Chloride	Potassium Chloride	103	31
Tamsulosin Hcl	Tamsulosin Hcl	99	35
Allopurinol	Allopurinol	97	27
Tramadol Hcl	Tramadol Hcl	94	22
Oxycodone Hcl	Oxycodone Hcl	90	17
Metformin Hcl	Metformin Hcl	89	27
Spironolactone	Spironolactone	82	27
Hydralazine Hcl	Hydralazine Hcl	80	21
Prednisone	Prednisone	78	55
Eliquis	Apixaban	70	20
Duloxetine Hcl	Duloxetine Hcl	69	18
Atenolol	Atenolol	66	18
Zolpidem Tartrate	Zolpidem Tartrate	66	21
Lorazepam	Lorazepam	64	20
Finasteride	Finasteride	63	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	21
Escitalopram Oxalate	Escitalopram Oxalate	61	24
Trazodone Hcl	Trazodone Hcl	56	20
Clopidogrel	Clopidogrel Bisulfate	55	17
Chlorthalidone	Chlorthalidone	54	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	54	19
Mirtazapine	Mirtazapine	52	15
Tizanidine Hcl	Tizanidine Hcl	52	28
Ketoconazole	Ketoconazole	51	23
Meloxicam	Meloxicam	49	16
Alendronate Sodium	Alendronate Sodium	48	suppressed
Clonazepam	Clonazepam	45	suppressed
Ezetimibe	Ezetimibe	45	18
Metoprolol Tartrate	Metoprolol Tartrate	45	13
Synthroid	Levothyroxine Sodium	41	15
Pregabalin	Pregabalin	40	11
Glipizide	Glipizide	38	suppressed
Ibuprofen	Ibuprofen	38	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	38	suppressed
Diazepam	Diazepam	37	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Colchicine	Colchicine	36	17
Trulicity	Dulaglutide	36	suppressed
Valacyclovir	Valacyclovir Hcl	35	13
Valsartan	Valsartan	35	11
Azithromycin	Azithromycin	33	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Alprazolam	Alprazolam	32	suppressed
Mounjaro	Tirzepatide	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	28
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Lovastatin	Lovastatin	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	12
Paxlovid	Nirmatrelvir/Ritonavir	28	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Temazepam	Temazepam	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	22
Azelastine Hcl	Azelastine Hcl	26	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Fluconazole	Fluconazole	22	11
Fluocinolone Acetonide	Fluocinolone Acetonide	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	21	11
Lidocaine	Lidocaine	21	suppressed
Nateglinide	Nateglinide	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	12
Doxycycline Monohydrate	Doxycycline Monohydrate	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Amoxicillin	Amoxicillin	16	12
Cilostazol	Cilostazol	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	12
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Acyclovir	Acyclovir	14	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Ramipril	Ramipril	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Epinephrine	Epinephrine	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error